Intravenous immune globulin (New York University School of Medicine)

N/A

Report date: 2023/02/25 20:20:40

Base Information

Drug NameIntravenous immune globulin (New York University School of Medicine)
Drug Alias Name静脉注射用免疫球蛋白（New York University School of Medicine）
ClassificationBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNew York University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNew York University School Of Medicine
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A